Transplant Proc. 2013 Nov;45(9):3438-41. doi: 10.1016/j.transproceed.2013.07.054.
The liver graft as Trojan horse-multilineage donor-derived hematopoiesis after liver transplantation: case report.
Mark W, Ollinger R, Rumpold H, Wolf D, Nachbaur D, Aigner F, Margreiter C, Gassner C, Schennach H, Graziadei I, Vogel W, Margreiter R, Gunsilius E.
Hematopoietic macrochimerism, which is rarely seen after orthotopic liver transplantation (OLT), has been linked to the development of graft versus host disease (GvHD). We report on a patient with GvHD after OLT in whom full engraftment of donor-derived, multilineage hematopoiesis occurred, indicating that the liver contains pluripotent hematopoietic progenitor cells (HPC) capable to restore hematopoiesis in recipients. Although preventing graft rejection, standard immunosuppressive therapy may be under certain immunological conditions not sufficient to prevent GvHD. Age-, disease-, and treatment-related variables might be critical determinants for the development of an effective alloreactive T-cell response leading to the establishment of full hematopoietic chimerism. Copyright © 2013 Elsevier Inc. All rights reserved.